All posts tagged generic drugs

Generic drugs

Generic drug firm Watson completes acquisition of Actavis

US generic drugs maker Watson Pharmaceuticals Inc (NYSE:WPI) said it had finalised the acquisition of Swiss-Icelandic peer Actavis Group. The parties sealed the definitive agreement in April and received clearance by the European Commission in October. The merged company will …

Continue Reading...
generic drugs

Private equity firm TPG completes takeover of generic drug firm Par Pharmaceuticals

US private equity firm TPG Capital LP has completed the USD1.9bn (EUR1.5bn) takeover of generic and branded drugs maker and distributor Par Pharmaceutical Companies Inc (NYSE:PRX), the pair

biopharma

Switzeland’s Novartis agrees to acquire Fougera Pharmaceuticals for $1.53bn

Swiss drugmaker Novartis (NYSE:NVS) unveiled a USD1.525bn (EUR1.2bn) all-cash deal to take over US speciality dermatology generics firm Fougera Pharmaceuticals Inc from a group of private equity funds

Euro in crisis

US-based Watson seals a deal to acquire Icelandic generic drugmaker Actavis

US generic drugs maker Watson Pharmaceuticals Inc (NYSE:WPI) has reached a deal to take over Icelandic peer Actavis Group for an initial price of EUR4.25bn (USD5.6bn), plus a

Powered by WordPress